Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to lead a push to turn Wakix into a blockbuster and prepare to launch other ...

Benjamin Ping, General Manager of Takeda Vietnam, likens the company to bamboo, symbolizing resilience, strength, and adaptability, blending core values, a robust team, and flexible strategies to ...

The link between optimal calcium intake and reduced CRC risk is well-established, said William Grady, MD, a professor and medical director of the Gastrointestinal Cancer Prevention Program at Fred ...

That first-party exclusivity kind of mitigates the sticker shock, if you will, of these price hikes, because you want that content so bad." Nintendo Switch 2 pricing in the U.S.: Nintendo Switch 2 ...

Takeda has partnered with patient data firm Seqster in a drive to improve care through better access and understanding of patient-level data. The partnership follows Takeda's investment in the US ...

The most common approach has been the time-honored way political messages have been conveyed by automobile owners for decades: bumper stickers. You’ve probably seen the “I Bought This Before ...

Since at least November, more than 150 animals have been sent out of Worcester as the city’s only animal shelter refuses new intakes due to reaching capacity, creating a growing crisis for the ...

Simple, evidence-backed choices, such as opting for plastic-free tea bags, filtering drinking water, and selecting natural fabrics, significantly lower MP intake. By understanding the sources and ...

Takeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for coeliac disease to its pipeline. The Japanese pharma decided to buy San Diego-based PvP ...

The city of Chicago is giving anyone who doesn't have a city vehicle sticker a break for the entire month of April. The office of the Chicago City Clerk is calling next month Amnesty April.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...